News
PLEASANTON, Calif., March 26, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the commercial availability of its Visium HD Spatial ...
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the commercial availability of its Visium HD Spatial Gene Expression product. This assay enables ...
Earnings Call Insights: 10x Genomics (NASDAQ:TXG) Q4 2023 Management View CEO Serge Saxonov highlighted strong growth across ...
10x Genomics has begun commercial shipping of its long-awaited Visium HD Spatial Gene Expression instrument this week, a next-generation version of the company’s Visium spatial biology tool, two ...
Spontaneous Russell (left) is a Staff Product Manager for Visium Spatial Gene Expression technologies from 10x Genomics (CA, USA). She has spent the last 20 years leading product development and ...
A team of 10x Genomics scientists conducted a comprehensive analysis of human breast tumor microenvironments using all three of its industry-leading platforms PLEASANTON, Calif., Dec. 19, 2023 ...
PARIS and PLEASANTON, Calif., Oct. 31, 2024 /PRNewswire/ -- French TechBio startup Cure51 and 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that ...
PARIS and PLEASANTON, Calif., Oct. 31, 2024 /PRNewswire/ -- French TechBio startup Cure51 and 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that ...
PARIS, Oct. 31, 2024 /PRNewswire/ -- French TechBio startup Cure51 and 10x Genomics, Inc., a leader in single cell and spatial biology, announced today that Cure51 will deploy 10x Genomics' Visium ...
PARIS, Oct. 31, 2024 /PRNewswire/ -- French TechBio startup Cure51 and 10x Genomics, Inc., a leader in single cell and spatial biology, announced today that Cure51 will deploy 10x Genomics' Visium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results